Preventing smoking, lowering cholesterol, controlling blood
Stress and Healing Hepatitis C will significantly reduce the burden of the heart
AIDS, AIDS, terminal liver disease, and kidney disease
People living with HIV, according to analysis of a large group of North America, published in the journal Lancet HIV.
The study found that the elimination of traditional risk factors for these conditions would have a far greater effect than the optimal treatment of HIV on the prevalence of conditions, with an emphasis on the importance of screening and managing these conditions in the lifelong treatment of people living with HIV.
As antiretiriral therapy has extended the lives of people
With HIV and significantly reduced the number of deaths from AIDS-defined diseases,
AIDS such as cardiovascular disease, end-stage liver disease
Cancer has become the most important cause of death in people living with
HIV in countries with higher incomes.
Although HIV is known to increase the risk of cardiovascular disease
Diseases and some cancers, the relative contributions of HIV-related risk
Factors and other risk factors for the development of these conditions in people
Life with HIV was not clear. As a result, the screening of risk factors,
Interventions to reduce the risk factors for these conditions, not always
NA-ACCORD brings together the clinical cycles of living people
With HIV in more than 200 sites in North America. Together, these groups have
Following 180,000 patients who participated in the clinic at least twice.
This analysis of participants in the study group looked at people
With at least two clinic visits between January 2000 and December 2014.
All cases of heart attack, AIDS definition of cancer, end stage liver disease
And kidney disease in the final stage, which occurred after the start of follow-up
Were evaluated for risk factors associated with unrelated HIV and HIV
The participants at the time had no diagnosis
Risk factors associated with HIV were low in CD4 count,
Detectable viral load, diagnosis of HIV and antiretroviral drugs.
Non-HIV risk factors were evaluated and were smoking, elevated
General Cholesterol, Hypertension, Diabetes, Stage 4 Chronic Kidney Disease,
Prescription statins in hepatitis B or C. age, sex, race and HIV
Traffic classifications were also considered.
Dr. Kerry Tathof of Johns Hopkins University calculated the portion of the population,
Or the percentage of cases that will prevent the population
The causal risk factor was removed. This index captures the effect of risk
Factors that may have a small personal impact but are common in the population as well as risk factors that have a much greater impact but are less common. This allows epidemiologists to judge
Which interventions that change risk factors are likely to be greatest
Influence at the population level.